Samuel Greenlee
Family Medicine · Pensacola, FLNPI 1871685925
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $234,148 of the $234,581 with a category attached, or 99.8%. 10 manufacturers reported payments, led by CSL Behring at 52.4% of the total. Among family medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 251 payments — averaging $934.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$123K
- CSL Plasma Inc.$111K
- Pfizer$266
- AbbVie$41
- Abbott$31
- GSK$31
- plus $64 from 4 others
What the payments were for
- Consulting fees$234,148100%
- Food & beverage$4320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 127 | $122,875 |
| CSL Plasma Inc. | 99 | $111,273 |
| Pfizer | 14 | $266 |
| AbbVie | 2 | $41 |
| Abbott | 2 | $31 |
| GSK | 2 | $31 |
| Lilly USA, LLC | 2 | $27 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Novo Nordisk | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
How this compares
$234,581 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SynthroidLevothyroxine Sodium | 28 | $2,827 |
| Lidocaine | 13 | $2,484 |
| Fentanyl | 12 | $2,050 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 62 | $1,847 |
| Omeprazole | 63 | $1,211 |
| Diclofenac Sodium | 16 | $974 |
| Ventolin HfaAlbuterol Sulfate | 13 | $692 |
| Gabapentin | 28 | $660 |
| Ibuprofen | 51 | $628 |
| Cyclobenzaprine Hcl | 18 | $572 |
| Carvedilol | 32 | $458 |
| Potassium Chloride | 29 | $441 |
| Atorvastatin Calcium | 34 | $438 |
| Simvastatin | 36 | $341 |
| Lisinopril | 39 | $331 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $41 | $2,82728 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Pensacola
- Mitchell WhiteheadPensacola$83K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.